ISSN: 2167-065X
Clinical Pharmacology & Biopharmaceutics
Open Access
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)Useful Links
Recommended Journals
Additional Info
Loading Please wait..
Up-regulation of Nur77 by HDAC inhibitors is important for neurite outgrowth
2nd International Summit on Clinical Pharmacy
December 02-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA
| Koji Shimoke, Takuma Tomioka, Hiroki Maruoka and Toshihiko Ikeuchi |
| Posters: Clinic Pharmacol Biopharm |
| DOI: 10.4172/2167-065X.S1.007 |
| Abstract |
| Histone deacetylase (HDAC) inhibitors can induce neuronal differentiation. The effect of HDAC inhibitors is not limited to neuronal differentiation but to cell survival. We have reported that treatment with HDAC inhibitors promotes neurite outgrowth and cell survival via expression of nerve growth factor IB (Nur77), one of the immediate early genes (IEG), in rat PC12 cells. While Nur77 leads to expression of a family of proteins, including Nor1, the function of Nor1 following HDAC inhibitor treatment remains unclear. Thus, we analyzed whether Nor1 is an essential gene product for neurite out growth in response to HDAC inhibitors, compared with the expression of Nur77 in response to forskolin (FSK), because FSK is known to induce neurite outgrowth. We used HDAC inhibitors (trichostatin A (TSA) or K-350) and FSK as a positive control for neurite outgrowth. We also added siRNA to deplete the expression of Nur77. The neurites were photographed using phase-contrast microscopy and the length of each neurite was measured using analysis software. We found that TSA and K-350 both induced neurite outgrowth accompanied with expression of Nur77 after treatment of the cells for 24 hours. We also observed that only FSK induced the expression of Nor1. Furthermore, siRNA against mRNA for Nur77 prevented the TSA-induced neurite outgrowth. These results suggest that while the expression of Nor1 is not essential, the expression of Nur77 is necessary for neurite outgrowth by HDAC inhibitors. |
 PDF |  HTML |
Relevant Topics
- Adverse Drug Reactions
- American Health Care Systems
- Anvisa Drug Safety Regulations
- Applied Biopharmaceutics
- Australian Health Care Systems
- Biopharmaceuticals Manufacturing and Industry
- Biopharmaceuticals Process Validation
- Biopharmaceutics and Drug Disposition
- Canadian Health Care Systems
- Clinical Drug Trials
- Clinical Management Systems
- Clinical Pharmacists
- Clinical Pharmacoepidemiological Trails
- Clinical Pharmacology
- Clinical Research Studies
- Clinical Trials Databases
- Drug Delivery
- Drug Safety Databases
- Drug Safety Information Maintenance
- Drug Safety Regulations
- Drug Side Effect
- Europeon Drug Safety Regulations
- Europian Health Care Systems
- Expert Opinions on Drug Safety
- Health Care Management Systems
- Health Information Systems
- Health Insurance Systems
- Health Polices
- Health Systems
- Health Systems Services
- Japan Health Care Systems
- Medical Billing Softwares
- Medical Software Companies and Software Analysis
- Medical Trails/ Drug Medical Trails
- Medication Errors
- Medication Management Services
- Methods in Clinical Pharmacology
- Molecular Pharmacology
- Neuropharmacology
- Observatory Health Policies
- Online Pharmacy
- Pharmaceutical Care Management
- Pharmaceutical Care Models
- Pharmaceutical Care Practice
- Pharmacoeconomics
- Pharmacoepidemiological Studies
- Pharmacoepidemiology
- Pharmacogenomics
- Pharmacokinetics
- Pharmacotherapeutics
- Pharmacotherapy
- Pharmacy Education
- Pharmacy Practice
- Preclinical safety evaluation of biopharmaceuticals
- Psychopharmacology
- Reviews on Drug Safety
- Systems Pharmacology
- Theoretical Pharmacology
- UK Drug Safety Regulations
- US Drug Safety Regulations
